“Lab-grown red blood cells have been transfused into volunteers in a clinical trial that could revolutionize the treatment of patients with sickle cell disease and thalassemia.”, relationships The Guardian. A first.
Both diseases are serious inherited diseases that affect hemoglobin, the blood protein that carries oxygen throughout the body. Their treatment requires personalized care with frequent blood transfusions, which is a problem when donors are in short supply or the patient’s blood type is rare.
“The vast majority of blood transfusions will always rely on those people who roll up their sleeves to donate blood, for its part ensures the site of the British chain BBC. Corn the objects
